Morningstar

Hologic Inc HOLX

Morningstar Rating
Unlock
Stock XNAS Rating as of
$79.77 −0.79 (0.98%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
HOLX is trading at a 754% premium.
Price
$79.77
Fair Value
$91.00
Uncertainty
Medium
1-Star Price
$33.90
5-Star Price
$65.00
Economic Moat
Sbcdjx
Capital Allocation
Vbbnfmbbs

Bulls Say, Bears Say

Bulls

Hologic was first to market with an FDA-approved 3D mammography platform in the U.S., giving it a considerable head start in its installed base against GE and Siemens.

Bears

Shifts in screening guidelines and disruptive technologies can have a significant effect on Hologic's business as we saw with the advent of HPV diagnostics on traditional Pap tests.

Show More

News

View All

Trading Information

Previous Close Price
$80.56
Day Range
$79.26–80.53
52-Week Range
$64.02–84.67
Bid/Ask
$79.38 / $80.35
Market Cap
$18.53 Bil
Volume/Avg
1.7 Mil / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
20.14
Price/Sales
4.81
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
5.33%

Company Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
6,990
Website
http://www.hologic.com

Competitors

Valuation

View More
Metric
HOLX
GE
BDX
Price/Earnings (Normalized)
 20.1448.1818.79
Price/Book Value
 3.7410.872.68
Price/Sales
 4.813.743.53
Price/Cash Flow
 16.4635.6519.04
Price/Earnings
HOLX
GE
BDX

Financial Strength

Metric
HOLX
GE
BDX
Quick Ratio
 3.060.811.20
Current Ratio
 3.991.141.85
Interest Coverage
 6.695.504.20
Quick Ratio
HOLX
GE
BDX

Profitability

Metric
HOLX
GE
BDX
Return on Assets (Normalized)
 10.67%2.95%3.65%
Return on Equity (Normalized)
 19.28%16.76%7.60%
Return on Invested Capital (Normalized)
 12.50%9.68%5.30%
Return on Assets
HOLX
GE
BDX

Medical Instruments & Supplies Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
FppsrrnnsTvch$172.9 Bil
 Becton Dickinson & Co
BDX
YfxcjgbtXhvnb$69.3 Bil
 Alcon Inc
ALC
QshspfgqTsdfrg$49.2 Bil
 ResMed Inc
RMD
XrrrlvmryzGhvpy$35.1 Bil
 Coloplast AS ADR
CLPBY
GxlrrrtqqxQnc$29.2 Bil
 West Pharmaceutical Services Inc
WST
WjczkpkfwJblgz$21.7 Bil
 The Cooper Companies Inc
COO
BpmdywzzVlywy$21.5 Bil
 Baxter International Inc
BAX
HfnxwjygCltyxrn$18.4 Bil
 Align Technology Inc
ALGN
JmxdplbkMythdh$17.8 Bil

Sponsor Center